Main results
Six studies were included in earlier versions of the review. In this update two of the previously included papers have been excluded and two new trials have been added. Of these six trials, four compared gauze and tape with transparent polyurethane dressings (total participants = 337) and two compared different transparent polyurethane dressings (total participants = 126). Catheter-related bloodstream infection was higher in the transparent polyurethane group when compared with gauze and tape; OR 4.19 (95%CI 1.02 to 17.23) however these small trials were at risk of bias so this evidence is graded low quality. There was no evidence of a difference between highly permeable polyurethane dressings and other polyurethane dressings in the prevention of catheter-related bloodstream infection (low quality evidence). No other significant differences were found.
Authors' conclusions
We found a four-fold increase in the rate of catheter related blood stream infection when a polyurethane dressing was used to secure the central venous catheter however this research was at risk of bias and the confidence intervals were wide indicating high uncertainty around this estimate; so the true effect could be as small as 2% or as high as 17-fold. More, better quality research is needed regarding the relative effects of gauze and tape versus polyurethane dressings for central venous catheter sites.
P L A I N L A N G U A G E S U M M A R Y

Different dressings used to protect the central venous catheter site with the aim of reducing the chance of developing a catheterrelated infection
A central venous catheter is a small tube inserted into a major vein to allow medications and other fluids to be 'dripped' into the body over time without repeated injections. It is used in preference to a peripheral catheter (e.g. in the hand or arm) when access is required for long periods of time, or when the fluids being administered are damaging to the tissues. However, because central catheters are open to large veins they are associated with a risk of blood infection. Several different kinds of dressing are used for protecting the central venous catheter site, including transparent polyurethane dressings, and gauze and tape. These dressings may vary in their durability, ease of use, ability to prevent infections and skin reactions. We reviewed all relevant medical trials to identify any differences between dressings, particularly with respect to differences in infection rates. We found that there were fewer catheter-related infections in the group using gauze and tape but the evidence was low quality and larger, better quality studies are needed confirm these findings. 
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation
B A C K G R O U N D
Central venous catheters (CVCs) are used increasingly within the hospital setting. The placement of a CVC in a central vein allows the intravenous administration of complex drug treatments, blood products and nutritional support without the trauma associated with repeated needle insertions (venepuncture). However, CVCs are associated with a higher incidence of bloodstream infection then peripheral catheters (Maki 2006) . Organisms from the patient's skin are a major source of catheter-related infection, especially in the first one to two weeks following insertion (Mermel 2011) .
Traditionally, the CVC site would be dressed with dry gauze and tape, but in the early 1980s these gave way to transparent polyurethane dressings, notably Opsite® (Smith & Nephew Healthcare Ltd), Tegaderm® (3M) and, more recently, Opsite IV3000® (Smith & Nephew Healthcare Ltd). There are substantial differences between different transparent polyurethane dressings, including size, permeability and weight (Thomas 1988) , and possible clinical advantages of increased durability, improved security of the catheter, visibility of the wound site, and provision of an effective barrier to micro-organisms. As some dressings may be more conducive to the growth of micro-organisms on the skin, the type of dressing applied to the catheter insertion site may influence the incidence of catheter-related infections (Callahan 1987; Maki 1992; Schwartz-Fulton 1981; Treston-Aurand 1997) . There is concern that transparent polyurethane dressings increase skin surface humidity, which may result in increased bacterial colonisation of the site, and therefore, an increased risk of catheter-related infection (Conly 1989; Dickerson 1989; Wille 1993) . Therefore, dressings such as Opsite IV3000 -a highly vapour permeable transparent polyurethane dressing (Wille 1993) -that increases the rate of evaporation of fluid from the CVC site may decrease the risk of infection.
Despite the possible risks associated with CVC dressings, there appear to be no clear recommendations regarding their suitability. The recommendations for the prevention of intravascular devicerelated infections published by the US Centers for Disease Control and Prevention direct to: "Use either sterile gauze or sterile, transparent, semipermeable dressings to cover the catheter site" (O'Grady 2011). Before embarking on the first edition of this review we searched the Cochrane Database of Systematic Reviews (CDSR) and the Database of Abstracts of Reviews of Effectiveness (DARE) to identify pre-existing reviews. No Cochrane review addressing CVC dressings was found, but a meta-analysis that compared the effects of dressing types for peripheral and central catheters was identified from DARE (Hoffmann 1992) . This meta-analysis reported that the risk of catheter tip colonisation (but not catheter-related blood stream infection) was significantly increased with transparent CVC dressings compared with gauze and tape. However, this analysis of seven studies included two studies with an additional intervention in one dressing group only (Andersen 1986; Powell 1982) ; one study that allocated patients on the basis of where they were nursed (not randomly) (Young 1988) ; and one study where the data were not from a patient sample (Conly 1989) . Therefore, several factors in this meta-analysis could have biased its results. Furthermore, several new studies on this topic have been published since the Hoffmann 1992 review went to press (the search date for this review went up to mid 1991), and these data needed to be evaluated.
The lack of clear evidence regarding the most appropriate dressing for CVCs established the need to undertake this systematic review. This review was undertaken to determine whether there was any difference between gauze and tape and transparent polyurethane dressings in relation to CVC-related infection, catheter security, tolerance to dressing material and dressing condition.
O B J E C T I V E S
To compare gauze and tape with transparent polyurethane dressings for central venous catheters, in terms of catheter-related infection, catheter security, tolerance to dressing material and dressing condition in hospitalised adults and children.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials (RCTs) comparing the effects of gauze and tape with transparent polyurethane dressings, or comparing different transparent polyurethane dressings on CVC or skin colonisation, catheter-related bacteraemia (presence of bacteria in the blood), local or tunnel (following the route of the catheter) infection, catheter security, tolerance to dressing material and dressing condition in hospitalised patients. Studies with more than 50% loss to follow-up were excluded. Whilst we did not state explicitly in our protocol that studies where comparison arms had different co-interventions would be excluded, this was how we interpreted the protocol. We also excluded trials where the central line was peripherally inserted.
Types of participants
Patients, of any age, in the hospital setting, with CVCs in situ.
Types of interventions
Studies which compared gauze and tape CVC dressings with transparent polyurethane CVC dressings, or compare different transparent polyurethane CVC dressings.
Types of outcome measures
Primary outcomes
• Incidence of catheter-related bloodstream infection: isolate of the same organism from a semi-quantitative or quantitative culture of a catheter segment and from separate percutaneous blood cultures, with no other identifiable source of infection.
• Incidence of positive catheter cultures: any positive semiquantitative or quantitative culture from a proximal or distal catheter segment.
• Incidence of skin/site colonisation (mean number of colony-forming units): any positive semi-quantitative or quantitative culture from the skin around the catheter site.
As these outcomes are measured by methods that have accepted validity and reliability these data will be collected from included studies even where reliability and validity were not shown.
Secondary outcomes
• Incidence of exit-site infection.
• Incidence of tunnel infection.
• Incidence of catheter security.
• Incidence of skin irritation.
• Dressing condition/durability (incidence or mean score).
Data for these outcomes were only collected from included studies if the measures used were shown to be valid and reliable. Any measure that had only face validity and had not been tested for reliability by methods such as inter-rater agreement was not considered to be valid and reliable.
Search methods for identification of studies
For the search methods used in the second update of this review see Appendix 1. For this third update we searched the following electronic databases to find reports of relevant randomised controlled trials (RCTs):
• The Cochrane Wounds Group Specialised Register (searched 10 May 2011);
• 
Data collection and analysis
Selection of studies
Two review authors assessed all potentially relevant references for eligibility. Where necessary, we obtained abstracts of potentially relevant papers or full papers in order to assess further studies for inclusion. Where differences of opinion regarding eligibility occurred, they were resolved by discussion or by referral to a third member of the team.
Data extraction and management
Two members of the review group independently extracted data from each study. Differences of opinion were resolved either by consensus or by referral to a third member of the team. If data were missing from trial reports, we contacted study authors for additional information. Data extracted included:
• Country and setting where the study was performed.
• Inclusion and exclusion criteria.
• Details of intervention.
• Outcomes measured.
• Duration of study.
• Numbers enrolled and completing in each group.
• Baseline characteristics of each group.
• Results per group.
Assessment of risk of bias in included studies
Two review authors independently assessed the quality of eligible trials (JW,KS) using the Cochrane Collaboration tool for assessing risk of bias (Higgins 2011) . This tool addresses six specific domains, namely sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and other issues which may potentially bias the study (see Appendix 5 for details of criteria on which the judgement was based). Blinding and completeness of outcome data were assessed for each outcome separately. A risk of bias table was completed for each eligible study. Disagreements between authors were resolved by consensus or referral to a third author. We attempted to contact investigators of included trials to resolve any ambiguities. Assessment of risk of bias is presented using a 'risk of bias summary figure' , which presents all the judgements in a cross-tabulation of study by entry.
Measures of treatment effect
Event rates for binary outcomes (e.g., infection rates) are presented as odds ratios (OR) and 95% confidence intervals (CI). For continuous outcomes we calculated the difference in means with 95% confidence intervals (CI). Skewed data were not used. Skew could only be defined when a scale started from zero. If the standard deviation, multiplied by two, was greater than the mean then the distribution of data was deemed to be skewed (Altman 1996) .
Assessment of heterogeneity
We tested for statistical heterogeneity by performing a chi-squared test (chi 2 ). We assessed the extent of heterogeneity using the I 2 statistic (Deeks 2011). This examines the percentage of total variation across studies due to heterogeneity rather than to chance. Values of I 2 over 75% indicate a high level of heterogeneity. Where a high level of heterogeneity was found, a random-effects model was used for pooling. If the results of a random-effects analysis were substantially different from the fixed-effect analysis, the studies responsible for heterogeneity were not to be added to the main body of homogeneous trials, but were to be summarised and presented separately.
Assessment of reporting biases
Wherever possible, data from all included studies were to be entered into a funnel graph (trial effect against trial size) in an attempt to investigate the likelihood of overt publication bias (Egger 1997)
Subgroup analysis and investigation of heterogeneity
Planned sub-group analyses were:
• Adult and paediatric patients.
• Frequency of dressing changes.
Sensitivity analysis
Planned sensitivity analysis was based on concealment of allocation (allocation adequately concealed vs unclear / inadequate allocation concealment).
R E S U L T S Description of studies
See: Characteristics of included studies and Characteristics of excluded studies for further details.
Of the 28 full papers and abstracts considered in previous versions of this review, six studies met the inclusion criteria and were included in the original review (Brandt 1996; Hägerström 1994a; Neufeld 1991; Petrosino 1988a; Shivnan 1991; Wille 1993 All the included studies reported patient data for at least one of the primary outcomes of this review (de Barros 2009; Brandt 1996; Giles 2002; Neufeld 1991; Shivnan 1991; Wille 1993) , and three studies reported secondary outcomes (Brandt 1996; Neufeld 1991; Shivnan 1991) . The data for dressing changes from the study by Neufeld 1991, however, were skewed and so were not added to the meta-analysis, therefore, data for secondary outcomes were available from two included studies. 
Excluded studies
In an earlier version of this review 22 papers and abstracts from 18 trials were excluded. In summary: three trials were not RCTs (Reynolds 1987; Wheeler 1988; Young 1988) ; four had a co-intervention other than the dressing type in one group only (Andersen 1986; Little 1998; Nehme 1984; Powell 1982) ; one used gauze in both groups (Lawson 1986); it was not possible to assess whether five studies met the eligibility criteria for this review (Dickerson 1989; Freiberger 1992; Maki 1992; Ricard 1985; Thomas 1977 
Risk of bias in included studies
Allocation
Sequence generation
Only two of the six trials described an adequate method for sequence generation (Giles 2002; Shivnan 1991) .
Allocation concealment
An adequate method of allocation concealment was reported in only one trial (de Barros 2009).
Blinding
Blinding of personnel and participants
This was not possible in trials where gauze and tape were compared with transparent polyurethane dressings (de Barros 2009; Brandt 1996; Giles 2002; Shivnan 1991) . Blinding of personnel and participants was not mentioned where one transparent polyurethane dressings was compared with another transparent polyurethane dressings (Neufeld 1991; Wille 1993) .
Blinding of outcome assessor
Neufeld 1991 reported that an independent assessor conducted a blind assessment on each central line on a daily basis. In this study, the laboratory assessments were also blinded. In the Brandt 1996 trial, microbiological processing of samples was also blinded. The remaining four studies did not report on this aspect of blinding.
Incomplete outcome data
All of the included studies reported the number of patients lost to follow-up , which ranged from 0 to 40%. Four trials were graded as having a low risk of reporting bias (Brandt 1996; de Barros 2009; Giles 2002; Wille 1993) . Some participants in three of these trials were excluded from the analysis following randomisation and data were analysed on an 'as-treated' basis by the original trialists (Brandt 1996; Giles 2002; Wille 1993) . The nature of reporting in one study made it unclear whether all participants had been included in the analyses ( Shivnan 1991). For the remaining trial (Neufeld 1991;) reporting of data was incomplete, these studies were assessed as having a high risk of reporting bias.
Selective reporting
All trials provided information for all of the of outcomes prespecified in the paper (protocols were not accessed for any of the studies). None of our primary outcome measures were reported in all reports. 
Other potential sources of bias
It was difficult to determine if there were 'unit of analysis' issues in two trials where dressings, rather than participants, were randomised (Giles 2002; Neufeld 1991) . In one trial of highly vulnerable oncology patients, a range of antibiotics was administered during the study period but it was unclear if antibiotic use was evenly distributed between treatment groups (Shivnan 1991). Finally, half of the trials received partial or full manufacturer sponsorship (Neufeld 1991; Shivnan 1991; Wille 1993) . No site colonisation occurred in either group when one transparent polyurethane dressings (Opsite) was compared with a different transparent polyurethane dressing (Opsite 3000) (OR not estimable). All data for this analysis came from the study by Neufeld 1991 which had a total sample size of 25.
Effects of interventions
Although it was proposed that data from all included studies were to be entered into a funnel graph (trial effect against trial size) in an attempt to investigate the likelihood of overt publication bias (Egger 1997), this was not possible due to the small number of included studies.
D I S C U S S I O N Summary of main results
This systematic review compared gauze and tape with any type of polyurethane dressing designed to secure a central venous catheter. Outcomes analysed were catheter-related blood stream infection, catheter colonisation, skin/site colonisation, exit site infection and tunnel infection. Despite the relatively high number of studies identified as relevant to this review, few could be included. The major reasons for exclusion were the number of studies without adequate information, and studies where there was an intervention -apart from dressing type -that could have accounted for any differences between groups. We found a four-fold increase in the rate of catheter related blood stream infection when a polyurethane dressing was used to secure the central venous catheter. However, the confidence intervals were wide, indicating high uncertainty around this estimate; the true effect could be as small as 2% or as high as 17-fold. More research is needed to reduce the uncertainty around the size of the difference. Rates of catheter-related blood steam infections (between 0% and 6%) were similar to those reported in prior research (Maki 2006) , irrespective of the type of product used.
There have been suggestions that highly vapour permeable transparent polyurethane dressing may be superior to other types of transparent dressings (Wille 1993). However, a complete lack of heterogeneity in our analyses indicates that, at this stage, there is no evidence of difference between these types of dressings for the prevention of catheter-related blood stream infection. In terms of other primary outcomes, it is impossible to draw any conclusions about the effectiveness of each of the dressing types from the included studies. This is because data for each of the analyses came from a limited number of studies, the largest of which reported data from 101 participants. Therefore, all of the included studies were underpowered to detect clinically important differences, should they exist. In particular, the sample sizes in the individual studies would have been too small to identify any difference in the incidence of catheter-related bloodstream infection, as statistically significant. Given the incidence of approximately 3.3% of catheter-related bloodstream infection in this review, data from approximately 2260 patients would be required to show a halving in the incidence of catheter-related bloodstream infection, and much larger numbers required to show a smaller effect size.
Overall completeness and applicability of evidence
Most of the trials included in this systematic review addressed the review's most important outcome, catheter-related bloodstream infection, albeit with very small samples. Other outcomes of clinical interest, however, such as exit site infection, positive catheter cultures, skin reaction and catheter security were poorly reported, and many could not be extracted for this review.
In terms of applicability of evidence, although the participants were drawn from oncology, haematology and general surgical cohorts, intensive care patients -who are high users of central lineswere not represented in any of the trials included in the review. In addition, all outcomes were underpowered for demonstration of differences between groups, so support for external validity is low.
Quality of the evidence
Risk of bias was difficult to assess in most of the studies due to poor reporting. Only one trial supplied sufficient information for us to judge allocation concealment ( de Barros 2009), and it was unclear in most of the trials whether those assessing the outcome were blinded to intervention group. It was not possible to blind the participants or personnel to the gauze and tape intervention as dressings were dissimilar. In one trial (Shivnan 1991), more patients in the gauze group than the polyurethane group received prophylactic vancomycin when the catheter was inserted, which may have had an impact on results. Other issues involved inability to confirm evidence from authors. The Summary of findings for the main comparison therefore identifies that the evidence for the effects of these alternative dressings on catheter-related bloodstream infection, exit-site infection and positive catheter culture, is low quality. Finally, half of the trials received partial or full manufacturer sponsorship. It was not clear in these trials whether any publication restrictions had been placed upon authors.
Potential biases in the review process
Clearly described procedures were followed to prevent potential bias in the review process. A careful literature search was conducted and the methods we used are transparent and reproducible. None of the authors has any conflict of interest.
Agreement or disagreement with other studies or reviews
In their review of eight controlled clinical trials examining interventions for preventing infectious complications in haemodialysis patients with CVCs, McCann 2010 found no difference in exit site infection or catheter-related bacteraemia when polyurethane dressings were compared with gauze dressings. By contrast, Hoffmann 1992 found that use of transparent dressings to secure CVCs was associated with a higher risk of catheter tip infection (risk ratio (RR) 1.38; 95% CI 1.69 to 2.95). She also found a non-significantly higher rate of catheter-related bloodstream infection and bacteraemia in the polyurethane group. Nonetheless, the Hoffmann review was not limited to RCTs, and included data from letters, abstracts and other reports (Hoffmann 1992).
A U T H O R S ' C O N C L U S I O N S
Implications for practice
The review found that gauze and tape as a dressing to secure central venous catheters was associated with lower rates of catheter-related bloodstream infection than transparent polyurethane dressings. However, individual studies included in the review were small and at risk of bias. We found no evidence of effect for either gauze and tape or polyurethane dressings in the prevention of any of the other outcomes included in this review.
Implications for research
Information about important factors such as cost, patient and clinician preference, and ease of use were not available for assessment in this review. These factors may influence choice of dressing, especially, where differences in clinical outcomes are small or unable to be demonstrated. Future primary research of CVC dressings should continue to measure catheter-related bloodstream infection and exit site infection, but should also include a formal, planned economic analysis, as well as an assessment of patient preference. Information about whether or not catheters are cuffed, and the location of catheter insertion are important, and should be included in future trials. In addition, other clinical data should be collected using standardised measures to facilitate comparisons and the application of evidence. Finally, the role of other dressings and technologies currently used to secure CVCs requires exploration. The quality of most of the evidence in this review was low and the trials were poorly reported. Following the CONSORT guidelines would add significantly to the usefulness of future trials (Schulz 2010). The authors would also like to acknowledge the contribution of D Carr, J Frost, R Gunning and I O'Brien who were review authors and contributed to the original review and subsequent updates, they are no longer active authors of this review.
A C K N O W L E D G E M E N T S
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R E F E R E N C E S
References to studies included in this review
C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of included studies [ordered by study ID]
Brandt 1996
Methods
RCT of gauze and tape vs highly-permeable transparent polyurethane dressing (Opsite IV3000) Incomplete outcome data (attrition bias) All outcomes
Low risk "Four patients (two Gauze and tape, two Opsite IV3000) with histories of pre-BMT skin sensitivity (e.g., secondary to drug rash, radiation skin reaction, abrasion) required an alternative dressing early after accrual and were taken off study." Comment: Four participants (2 from each group who had skin reactions to the trial product) were removed from the study after randomisation. Analysis was per-protocol rather than intention to treat (ITT). We subsequently conducted an ITT analysis, and results remained essentially the same Selective reporting (reporting bias) Low risk All of the paper's pre-specified outcomes were reported (protocol not accessed)
Other bias High risk More frequent dressings than specified in protocol in Opsite IV3000 group; 2 additional dressing changes in the Opsite IV3000 group in week one (21%), and in week two (31%). Additional dressing changes in dry sterile gauze dressing group n = 15 "The high incidence of subjects in the experimental dressing protocol requiring more frequent dressing changes than specified in the protocol limits the conclusions about exclusive effect of the assigned dressing on the development of CVC infection" Incomplete outcome data (attrition bias) All outcomes
Low risk "Of 76 CVCs inserted in 74 patients, four were excluded from the study:-one patient died on the second postoperative day, tip culture was not available in one and the remaining two catheters were occluded shortly after insertion." Comment: Analysis was per-protocol
Giles 2002 (Continued)
rather than intention to treat. We subsequently conducted an ITT analysis, and results remained essentially the same Selective reporting (reporting bias) Low risk All of the paper's pre-specified outcomes were reported (protocol not accessed)
Other bias High risk A co-intervention was used in the gauze and tape group (daily cleansing with 10% povidone iodine), making it difficult to determine which intervention was effective The unit of analysis in this study was the catheter (70 patients with 72 CVCs were included) -probable 'unit of analysis' issue
Neufeld 1991
Methods RCT of transparent polyurethane dressing (Opsite) vs highly-permeable transparent polyurethane dressing (Opsite IV3000) Blinding (performance bias and detection bias) All outcomes
Low risk "An independent assessor conducted a blind assessment on each central line dressing on a daily basis...The nurse researcher was unaware of which colour tab was indicative of which dressing, and was therefore unaware of which dressing was in the experimental or control group"
Incomplete outcome data (attrition bias) All outcomes
High risk 44 lines randomised; 25 lines included in analysis. ITT analysis not used. "Forty-four lines were randomised. Twenty five lines were included in the study. Nineteen lines were excluded. Reasons for exclusion were: nine lines were removed prior to the 48 hours post insertion initial site inspection. Five patients (6 lines) expired prior to the 48 hour initial site inspection; two lines were dropped from the study because the wrong dressing protocol was used; and one patient who had two central lines was transferred to another hospital prior to the initial site inspection"
Selective reporting (reporting bias) Low risk All of the paper's pre-specified outcomes were reported. (Masters thesis protocol not accessed.)
Other bias High risk Evidence: "variety of skill and number of nurses performing central line dressings... nurses were not tested to ensure protocol compliance" Comment: consider possible effect due to variances in dressing techniques Evidence: "absence of a pigtail on the single lumen central line required twice the number of dressing changes than the two and three pigtail central lines combined. Although lines were randomised to the control or experimental group, the type of line was not stratified to either the control or experimental group. The numbers for the type of line used were therefore not equally distributed and the numbers were too small to ascertain specific factors related to number of times dressings were changed in the no pigtail lines." Comment: unequal distribution amongst groups may have affected results
The unit of analysis in this study was the catheter (unclear how many participants were included) -probable 'unit of analysis' issue Industry-sponsored, unclear if any constraints imposed on results Incomplete outcome data (attrition bias) All outcomes
Shivnan 1991
Unclear risk "Five individuals did not complete the study because of unexpected discharge or transfer from the unit (n = 3) or because of dissatisfaction with the assigned dressing (n = 2)." Unclear whether drop outs were accounted for in analysis; "although skin cultures were collected from all of the subjects, difficulties in laboratory quality control allowed analysis of only the first 75 subjects"
Selective reporting (reporting bias) Low risk All of the paper's pre-specified outcomes were reported (protocol not accessed)
Other bias High risk n = 27 patients changed from assigned dressing. "prophylactic course of vancomycin administered to some patients at the time of catheter insertion" Industry-sponsored in part, unclear if any constraints imposed on results
Wille 1993
Methods RCT of transparent polyurethane dressing (Opsite) vs highly-permeable transparent polyurethane dressing (Opsite IV3000) Incomplete outcome data (attrition bias) All outcomes Low risk "The 13 patients not included in the analysis were evenly distributed between the two dressing groups ... and were excluded for the following reasons ...." Analysis was per-protocol rather than intention to treat. Although 11 percent of participants were excluded, we subsequently conducted an ITT analysis and results remained essentially the same Selective reporting (reporting bias) Low risk All of the paper's pre-specified outcomes were reported (protocol not accessed)
Other bias Unclear risk Industry-sponsored, unclear if any constraints imposed on results Only the gauze and tape group had Nobecutan (verified with authors). One arm of the study had a cointervention with the dressing, as a result it was not possible to assess the effects of the dressing from those of Nobecutan, the co-intervention Cochrane Wounds Group Specialised Register search strategy ((catheter* and venous) or (catheter* and central) or (central and venous and line*) or (hickman and catheter) or (broviac and catheter) or (cook and catheter)) and ((occlusive and dressing*) or (gauze and dressing*) or (tape and dressing*) or (polyurethane and dressing*) or (permeable and dressing*) or (transparent and dressing*) or (nonpermeable and dressing*) or tegaderm or opsite )
Abbreviations
D A T A A N D A N A L Y S E S
Unclear
Insufficient information to permit judgement of low or high risk of bias. This is usually the case if the method of concealment is not described or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.
3. Blinding -was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following.
• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of others unlikely to introduce bias.
High risk of bias
• No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.
Unclear
• Insufficient information to permit judgement of low or high risk of bias.
• The study did not address this outcome.
Were incomplete outcome data adequately addressed?
Low risk of bias
• No missing outcome data.
• Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias).
• Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size.
• Missing data have been imputed using appropriate methods.
High risk of bias
• Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size.
• 'As-treated' analysis done with substantial departure of the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
Unclear
• Insufficient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated, no reasons for missing data provided).
5. Are reports of the study free of suggestion of selective outcome reporting?
Low risk of bias
Any of the following.
• The study protocol is available and all of the study's pre-specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre-specified way.
• The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre-specified (convincing text of this nature may be uncommon)
High risk of bias
• Not all of the study's pre-specified primary outcomes have been reported.
• One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre-specified.
• One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect).
• One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.
• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
Insufficient information to permit judgement of low or high risk of bias. It is likely that the majority of studies will fall into this category.
Other sources of potential bias
Low risk of bias
The study appears to be free of other sources of bias.
High risk of bias
There is at least one important risk of bias. For example, the study:
• had a potential source of bias related to the specific study design used; or • had extreme baseline imbalance; or • has been claimed to have been fraudulent; or • had some other problem.
